Emergency Room (Adult) - UMMC
Return to Locations Search
Address:
2500 N. State St.
Jackson, MS 39216
Contact Us:
(601) 984-1000
Business Hours:
Open 24 hours
Parking:
Directions:
From North State Street, turn onto UMMC campus from the stoplight at University Drive (across from Back Yard Burgers). Turn right; at the stop sign, turn left to continue on University Drive. To drop off an emergency room patient, turn left at the red "Emergency" sign.
Our Care Specialties at this location:
Our Clinical Trials offered at this location:
Researchers at UMMC are committed to discovering innovative ways to prevent and treat the diseases that affect our daily lives. Clinical research studies play a vital role in the advancement of medicine and can improve the well-being of our families, friends, communities, and future generations. In this way, participation in clinical research studies furthers our vision to create "a healthier Mississippi."
Partnering with UMMC’s researchers may have many advantages, including:
- Gaining access to investigational treatments
- Increasing knowledge about your own health
- Giving the gift of improved health to our communities and future generations
- Contributing to the advancement of science by helping researchers learn more about how the human body and mind work or by helping find a cure or better treatments for diseases
| Clinical Trials | Publish Date | Description | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction ≥ 40% (LVEF ≥ 40%)IRB Number: 2020V0284
Published: January 14, 2022
View Locations
Clinical Trial Locations:
|
20220114161531 |
<div>The purpose of this study is to look at how well the study drug, Finerenone, works in patients <span style="font-size: 1rem; color: #0a0a0a;">with heart failure, to learn if the study drug is safe for the patients and how it </span><span style="font-size: 1rem;">affects the body</span></div> heart health 20103 Theresa Hutson rlong Heart Health |
||||||||||||
A Randomized, Open-label Study of Dapagliflozin in Patients with Type 2 Diabetes Admitted with Acute Heart FailureIRB Number: 2020-0133
Published: January 11, 2022
View Locations
Clinical Trial Locations:
|
20220111163702 |
This study is for patients with Type II diabetes and who have come to the hospital with symptoms of Acute Heart Failure (AHF). It is designed to compare usual care to using dapagliflozin along with the usual care to treat AHF in hospitalized patients. Dapagliflozin is an FDA approved medication that is already used to help patients manage Type II Diabetes. dictate-ahf;type 2 diabetes;heart health ESR-19-14538 Theresa Hutson Gabriel Hernandez Heart Health |
||||||||||||
MK-1242-035: A Pivotal Phase 3 Randomized, Placebo-controlled Vericiguat Outcomes Study in HFrEF (VICTOR)IRB Number: 2021V0793
Published: March 02, 2022
View Locations
Clinical Trial Locations:
|
20220302112702 |
This study is testing MK-1242 (vericiguat) in people with a certain type of heart failure. It will compare MK-1242 to placebo (inactive substance) when added to your existing heart failure treatment. You, your study doctor and the study staff won't know what study drug you are getting. MK-1242 is experimental. heart health;victor;mk-1242 MK-1242-035 Will Pierce lpapadimitriou Heart Health |
||||||||||||
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in older Adults (PREVENTABLE)IRB Number: 2020V0312
Published: January 15, 2021
View Locations
Clinical Trial Locations:
|
20210115100959 |
<span style="color: #000000; font-family: &quot;Source Sans Pro&quot;, &quot;Helvetica Neue&quot;, Helvetica, Roboto, Arial, sans-serif; font-size: 14px; background-color: #ffffff;">PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.</span><div><span style="color: #000000; font-family: &quot;Source Sans Pro&quot;, &quot;Helvetica Neue&quot;, Helvetica, Roboto, Arial, sans-serif; font-size: 14px; background-color: #ffffff;"><br></span></div> cardiac;heart;men's health;women's health;obesity;nutrition PREVENTABLE Theresa Hutson mehall Heart Health Women's Health |
||||||||||||
Prospective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF (PARAGLIDE-HF)IRB Number: 2020-2778
Published: January 12, 2022
View Locations
Clinical Trial Locations:
|
20220112135215 |
The purpose of this research study is to find out if the study drug, sacubitril/valsartan, is safe and has beneficial effects when added to conventional heart failure therapy in patients with heart failure with preserved ejection fraction who have been stabilized after being admitted to the hospital for new or worsening heart failure. CLCZ696DUS01 Theresa Hutson rlong Heart Health |
||||||||||||
Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of a Multi-Dose Regimen of Oral Varespladib-Methyl in Subjects Bitten by Venomous Snakes (BRAVO study – Broad-spectrum Rapid Antidote: Varespladib Oral for snakebite)IRB Number: 2021-1045
Published: January 24, 2022
View Locations
Clinical Trial Locations:
|
20220124232533 |
The purpose of this clinical research study is to learn more about the use of the study medicine, varespladib, for the treatment of snakebite. You or your child will receive a medication called Varespladib or placebo. Varespladib is an experimental treatment, meaning that it has not yet been approved by the Food and Drug Administration (FDA) for the treatment of snakebite. In this study, varespladib will be compared to a placebo. A placebo is a pill that looks exactly like the study medicine but does not contain any active ingredient, and has no therapeutic effect by itself. bravo;snakebite;varespladib-methyl (ly333013) OPX-PR-01 Simon Barinas dvearrier Emergency Medicine |
||||||||||||
Study of four-factor prothrombin complex concentrate, OCTAPLEX, in patients with acute major bleeding on direct oral anticoagulant (DOAC) therapy with factor Xa inhibitorIRB Number: 2021V0540
Published: March 31, 2022
View Locations
Clinical Trial Locations:
|
20220331163046 |
The purpose of this study is to demonstrate how well OCTAPLEX works at different doses in people who have acute major bleeding and are currently taking medication which make their blood thinner. octaplex;bleeding LEX-210 Tamara Brocks unandi Stroke/Traumatic Brain Injury |